sj-pdf-2-tam-10.1177_1758835921996506 – Supplemental material for A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

Autor:	Metzenmacher, Martin, Hans-Georg Kopp, Griesinger, Frank, Reinmuth, Niels, Sebastian, Martin, Serke, Monika, Waller, Cornelius Florian, Thomas, Michael, Eggert, Jochen, Schmid-Bindert, Gerald, Hoiczyk, Mathias, Christoph, Daniel Christian, Kimmich, Martin, Deuß, Burkhard, Seifert, Stephanie, Held, Swantje, Schuler, Martin, Herold, Thomas, Breitenbuecher, Frank, Eberhardt, Wilfried Ernst Erich
Rok vydání:	2021
Předmět:	110203 Respiratory Diseases FOS: Clinical medicine 111702 Aged Health Care FOS: Health sciences 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 111299 Oncology and Carcinogenesis not elsewhere classified
ISSN:	1758-8359
DOI:	10.25384/sage.14535084
Popis:	Supplemental material, sj-pdf-2-tam-10.1177_1758835921996506 for A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer by Martin Metzenmacher, Hans-Georg Kopp, Frank Griesinger, Niels Reinmuth, Martin Sebastian, Monika Serke, Cornelius Florian Waller, Michael Thomas, Jochen Eggert, Gerald Schmid-Bindert, Mathias Hoiczyk, Daniel Christian Christoph, Martin Kimmich, Burkhard Deuß, Stephanie Seifert, Swantje Held, Martin Schuler, Thomas Herold, Frank Breitenbuecher and Wilfried Ernst Erich Eberhardt in Therapeutic Advances in Medical Oncology
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::55c018e7950b1546fe09e886a3c2a5f4 Zobrazit plný text záznamu